Exploring Kidney Oxygenation Responses to Dapagliflozin, Exenatide, and Their Combination in Patients With Type 2 Diabetes and Chronic Kidney Disease: Observations From a Prespecified Pilot Study of a Randomized Crossover Trial.

Ellen M Apperloo,Hiddo J L Heerspink,Annemarie B Van Der Aart,Dennis Rouw,Daniël H Van Raalte,Klaas Hoogenberg,Niels Jongs,Marcel H A Muskiet

doi:10.2337/dc24-2244

Exploring Kidney Oxygenation Responses to Dapagliflozin, Exenatide, and Their Combination in Patients With Type 2 Diabetes and Chronic Kidney Disease: Observations From a Prespecified Pilot Study of a Randomized Crossover Trial.

Ellen M Apperloo, Hiddo J L Heerspink + Show 6 more

https://doi.org/10.2337/dc24-2244

Copy DOI

Export

Save

Cite

Journal: Diabetes care

Publication Date: Jan 10, 2025

#Chronic Kidney Disease #Diabetes Kidney Disease #Diabetes Kidney #Chronic Disease #Kidney Oxygenation #Randomized Crossover Trial #Crossover Trial #Kidney Disease

Abstract
Full-Text
Similar Papers

Abstract

Listen

Exploring Kidney Oxygenation Responses to Dapagliflozin, Exenatide, and Their Combination in Patients With Type 2 Diabetes and Chronic Kidney Disease: Observations From a Prespecified Pilot Study of a Randomized Crossover Trial.

Full Text

Published Version

Check institute access

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Diabetes care

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.

R Discovery Prime

Exploring Kidney Oxygenation Responses to Dapagliflozin, Exenatide, and Their Combination in Patients With Type 2 Diabetes and Chronic Kidney Disease: Observations From a Prespecified Pilot Study of a Randomized Crossover Trial.